We examined the relationship of these microRNAs with survival outcomes in pre-PD-1 inhibitor treatment melanoma biopsies and showed that miR-100-5p and miR-125b-5p, from the same microRNA network, were positively associated with survival benefit. Here, PDCD1 is linked to melanoma.